Home

Empirikus Visszavonul Említés hepatic steatosis as a marker of metabolic dysfunction maga Ananiver Olvas

Fatty Liver | Arteriosclerosis, Thrombosis, and Vascular Biology
Fatty Liver | Arteriosclerosis, Thrombosis, and Vascular Biology

A problem of proportions: estimates of metabolic associated fatty liver  disease and liver fibrosis in Australian adults in the nationwide 2012  AusDiab Study | Scientific Reports
A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study | Scientific Reports

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes |  Diabetology & Metabolic Syndrome | Full Text
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes | Diabetology & Metabolic Syndrome | Full Text

Frontiers | Gut Dysfunction and Non-alcoholic Fatty Liver Disease
Frontiers | Gut Dysfunction and Non-alcoholic Fatty Liver Disease

PDF] Hepatic Steatosis as a Marker of Metabolic Dysfunction | Semantic  Scholar
PDF] Hepatic Steatosis as a Marker of Metabolic Dysfunction | Semantic Scholar

Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk  Factor for Cardiovascular Disease
Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease

Role of hepatic fatty acid metabolism in the development of hepatic... |  Download Scientific Diagram
Role of hepatic fatty acid metabolism in the development of hepatic... | Download Scientific Diagram

Diagnostic and interventional circulating biomarkers in nonalcoholic  steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism -  Wiley Online Library
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library

Immunological mechanisms and therapeutic targets of fatty liver diseases |  Cellular & Molecular Immunology
Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology

The metabolic basis of nonalcoholic steatohepatitis - Chakravarthy - 2020 -  Endocrinology, Diabetes & Metabolism - Wiley Online Library
The metabolic basis of nonalcoholic steatohepatitis - Chakravarthy - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library

JCI - Parental metabolic syndrome epigenetically reprograms offspring  hepatic lipid metabolism in mice
JCI - Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice

Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome -  ScienceDirect
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome - ScienceDirect

Non-alcoholic fatty liver disease: the interplay between metabolism,  microbes and immunity | Nature Metabolism
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity | Nature Metabolism

Cancers | Free Full-Text | Abnormal Metabolism in the Progression of  Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic  Insights to Chemoprevention
Cancers | Free Full-Text | Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention

Thrombospondin 1 improves hepatic steatosis in diet-induced  insulin-resistant mice and is associated with hepatic fat content in humans  - eBioMedicine
Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans - eBioMedicine

IJMS | Free Full-Text | Metabolic Dysfunction-Associated Fatty Liver  Disease (MAFLD)—A Condition Associated with Heightened Sympathetic  Activation
IJMS | Free Full-Text | Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation

Links between metabolic syndrome and metabolic dysfunction-associated fatty  liver disease: Trends in Endocrinology & Metabolism
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease: Trends in Endocrinology & Metabolism

Association of metabolic dysfunction-associated fatty liver disease with  kidney disease | Nature Reviews Nephrology
Association of metabolic dysfunction-associated fatty liver disease with kidney disease | Nature Reviews Nephrology

Distinct contributions of metabolic dysfunction and genetic risk factors in  the pathogenesis of non-alcoholic fatty liver disease - ScienceDirect
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease - ScienceDirect

PDF] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic  steatosis | Semantic Scholar
PDF] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis | Semantic Scholar

Coagulation and Endothelial Dysfunction Associated with NAFLD: Current  Status and Therapeutic Implications
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications

Livers | Free Full-Text | Oxidative Stress in Non-Alcoholic Fatty Liver  Disease
Livers | Free Full-Text | Oxidative Stress in Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic  syndrome - The Lancet Diabetes & Endocrinology
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome - The Lancet Diabetes & Endocrinology

PDF) Hepatic Steatosis as a Marker of Metabolic Dysfunction
PDF) Hepatic Steatosis as a Marker of Metabolic Dysfunction

Nutrients | Free Full-Text | Hepatic Steatosis as a Marker of Metabolic  Dysfunction
Nutrients | Free Full-Text | Hepatic Steatosis as a Marker of Metabolic Dysfunction

A human pluripotent stem cell model for the analysis of metabolic  dysfunction in hepatic steatosis - ScienceDirect
A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis - ScienceDirect

Frontiers | Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and  Treatment
Frontiers | Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment